Facebook Twitter Linkedin NASDAQ Market NewsClick here to email authorNEXT STORYERYTECH Provides Update on Phase 2 Investigator Sponsored Trial of Eryaspase in Second-Line Acute Lymphoblastic LeukemiaPREV STORYFibroGen Announces New Roxadustat Data Presented at 2020 ERA-EDTA Virtual Congress